Taiwan Biomaterial Co., Ltd. (TPEX:6649)

Taiwan Biomaterial Income Statement

Financials in millions TWD. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Revenue	220.4	96.57	72.84	127.31	41.67
Revenue Growth (YoY)	128.22%	32.59%	-42.79%	205.48%	130.56%
Cost of Revenue	85.61	39.27	25.72	36.94	9.52
Gross Profit	134.8	57.31	47.12	90.37	32.15
Selling, General & Admin	50.41	37.46	38.57	32.79	23.46
Research & Development	23.55	31.08	22.78	32.12	65.41
Operating Expenses	73.96	68.54	61.35	64.91	88.87
Operating Income	60.83	-11.24	-14.23	25.46	-56.72
Interest Expense	-0.74	-0.8	-0.87	-0.97	-1.03
Interest & Investment Income	5.38	3.84	4.7	2.25	0.49
Currency Exchange Gain (Loss)	-	3.67	0.27	6.67	-0.63
Other Non Operating Income (Expenses)	-6.54	2.04	1.1	0.34	10.48
EBT Excluding Unusual Items	58.93	-2.49	-9.03	33.76	-47.4
Gain (Loss) on Sale of Assets	-	-	-	-	-0.04
Pretax Income	58.93	-2.49	-9.03	33.76	-47.44
Income Tax Expense	-	-0.76	1.1	-	-
Net Income	58.93	-1.73	-10.13	33.76	-47.44
Net Income to Common	58.93	-1.73	-10.13	33.76	-47.44
Shares Outstanding (Basic)	42	42	42	41	33
Shares Outstanding (Diluted)	42	42	42	41	33
Shares Change (YoY)	0.21%	-	2.73%	23.90%	-
EPS (Basic)	1.40	-0.04	-0.24	0.83	-1.44
EPS (Diluted)	1.40	-0.04	-0.24	0.83	-1.44
Free Cash Flow	47.33	14.74	-12.74	-6.36	-54.3
Free Cash Flow Per Share	1.12	0.35	-0.30	-0.16	-1.65
Dividend Per Share	1.000	-	-	0.200	-
Gross Margin	61.16%	59.34%	64.69%	70.99%	77.15%
Operating Margin	27.60%	-11.63%	-19.53%	20.00%	-136.10%
Profit Margin	26.74%	-1.79%	-13.91%	26.52%	-113.84%
Free Cash Flow Margin	21.47%	15.26%	-17.49%	-5.00%	-130.31%
EBITDA	77.47	0.99	-2.28	36.02	-51.8
EBITDA Margin	35.15%	1.03%	-3.14%	28.29%	-124.29%
D&A For EBITDA	16.64	12.23	11.94	10.55	4.92
EBIT	60.83	-11.24	-14.23	25.46	-56.72
EBIT Margin	27.60%	-11.63%	-19.53%	20.00%	-136.10%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.